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Market Report
Yr 
Ago
4 Wks
Ago 7/11/03
Livestock and Products,
 Average Prices for Week Ending
Slaughter Steers, Ch. 204, 1100-1300 lb
  Omaha, cwt . . . . . . . . . . . . . . . . . . . . .
Feeder Steers, Med. Frame, 600-650 lb
  Dodge City, KS, cwt . . . . . . . . . . . . . . .
Feeder Steers, Med. Frame 600-650 lb,
   Nebraska Auction Wght. Avg . . . . . . .
Carcass Price, Ch. 1-3, 550-700 lb
  Cent. US, Equiv. Index Value, cwt . . . .
Hogs, US 1-2, 220-230 lb
  Sioux Falls, SD, cwt . . . . . . . . . . . . . . .
Feeder Pigs, US 1-2, 40-45 lb
  Sioux Falls, SD, hd . . . . . . . . . . . . . . . .
Vacuum Packed Pork Loins, Wholesale,  
   13-19 lb, 1/4" Trim, Cent. US, cwt . . . .
Slaughter Lambs, Ch. & Pr., 115-125 lb
  Sioux Falls, SD, cwt . . . . . . . . . . . . . . .
Carcass Lambs, Ch. & Pr., 1-4, 55-65 lb
  FOB Midwest, cwt . . . . . . . . . . . . . . . . .
$61.74
*
87.12
96.66
38.50
*
*
84.17
165.04
$77.41
91.61
95.77
126.39
48.00
*
136.67
*
191.74
$75.20
     *
     *
117.86
42.50
     *
109.05
90.12
193.45
Crops,
 Cash Truck Prices for Date Shown
Wheat, No. 1, H.W.
  Omaha, bu . . . . . . . . . . . . . . . . . . . . . .
Corn, No. 2, Yellow
  Omaha, bu . . . . . . . . . . . . . . . . . . . . . .
Soybeans, No. 1, Yellow
  Omaha, bu . . . . . . . . . . . . . . . . . . . . . .
Grain Sorghum, No. 2, Yellow
  Kansas City, cwt . . . . . . . . . . . . . . . . . .
Oats, No. 2, Heavy
  Minneapolis, MN , bu . . . . . . . . . . . . . .
3.53
2.00
5.55
3.71
1.87
3.25
2.31
6.14
3.94
1.75
3.11
2.07
5.98
3.63
1.54
Hay,
 First Day of Week Pile Prices
Alfalfa, Sm. Square, RFV 150 or better
  Platte Valley, ton . . . . . . . . . . . . . . . . . .
Alfalfa, Lg. Round, Good
  Northeast Nebraska, ton . . . . . . . . . . . .
Prairie, Sm. Square, Good
  Northeast Nebraska, ton . . . . . . . . . . . .
107.50
72.50
97.50
117.50
60.00
127.50
115.00
70.00
     *
* No market.
On July 2 the European Parliament approved a new
regulation governing Genetically Modified Organisms
(GMOs) that includes a requirement for products with more
than 0.9 percent of biotech material to be labeled as: “This
product is produced with GMOs.” The regulation also
includes provisions for tracing GMOs at all stages of
production. The regulation is expected to be approved by
the Council of Ministers of Agriculture and pass into law
before the end of the summer. The introduction of strict
traceability and labeling requirements by the European
Union (EU) is the latest event in an on-going dispute
between the EU and the U.S. regarding Genetically Modi-
fied Products (GMPs).
The dispute between the EU and the U.S. around GMPs
is the outcome of market interaction between parties
holding significantly different views on the need for
regulation of products of biotechnology. While the EU
advocates mandatory labeling (or even banning) of GMPs
based on its “precautionary principle” and the vocal
consumer opposition to these products, the U.S. has argued
the “substantial equivalency” of GMPs to their conven-
tional counterparts and have been opposing the labeling of
these products. 
What is interesting is that both parties' arguments seem
reasonable. Specifically, the U.S. is correct in claiming that
the existing scientific evidence shows that GMPs are as safe
as their conventional counterparts (i.e., "substantially
equivalent"), and the EU is also correct in claiming that the
long-term health and environmental effects of genetic
modification are currently unknown (which justifies
"precautions"). 
At the heart of the debate are, in my view, conflicting
interests with respect to the development and adoption of
the new technology. Governments are elected to serve the
interests of their respective countries and that’s exactly
what the EU and the U.S. are doing. In particular, the EU
has every incentive to constrain the development and
adoption of a technology that its consumers have expressed
an aversion against, and the U.S. has every incentive to
open up the markets for GMPs, since it is a major producer
of these  products and the major developer of the technol-
ogy. Recent reports estimate the loss to the American
producer due to the EU policy on GMPs to be around $1
billion/year. Whether the figure is right or not, it does create
pressure for the U.S. administration to “act.”
There are several questions about the new EU regula-
tion that I will try to address below.
1. What caused the EU to move from banning GM
crops to passing legislation that requires labeling? 
The answer here is external pressure. The introduction
of the new rules is, at least in part, a response to the recent
complaint filed with the WTO by the U.S., Canada and
Australia that challenges the effective EU ban on GM
products that has been in place since 1998.
It needs to be understood that the new traceability and
labeling requirements are consistent with the WTO position
on the issue that backs strict labeling of GMPs. EU’s
resistance received support last year when a global treaty
restricting GMOs (known as the  Cartagena Protocol on
Biosafety and supported by the U.S.) was approved! Even
though the U.S. has reacted to the costs imposed by the new
rules, the odds of winning a WTO challenge on the issue
are not very good.
2. Is the new regulation consumer-driven or is it a
political move as a non-tariff trade barrier?
If the polls on European consumer attitudes toward
GMPs mean anything at all, the European consumer
opposition to GMOs is very real. Recent polls show
consumer opposition to products of biotechnology in places
like France, Germany and Greece being as high as 85
percent.
Is this consumer opposition the reason behind the EU
position on GMOs or is it just an excuse for the introduc-
tion of trade barriers to the European market? The answer
depends on whom you ask. The EU contends that its policy
is a simple response to its consumer demands and the
existing uncertainty about the long-term effects of GMOs
while the U.S. (and others) have characterized it as a
European trick to justify the trade barrier - simple protec-
tionism. One can only speculate. The fact though is that the
introduction of mandatory labeling satisfies European
consumers while creating barriers to exports of GMOs in
the EU.
3. What is the likely impact of this legislation on third
countries?
Countries that trade with the EU and seek to export GM
crops to the EU will need to bring their regulatory frame-
works in line with the European one.
For many producers, however, the costs of meeting the
European standards will be prohibitively high. In fact, I
expect the new rules to deter adoption of GM technology in
developing countries where the transaction costs associated
with the new traceability and labeling requirements will be
very high (and certainly higher than any production cost
savings generated by the adoption of the current, producer-
oriented GM technology).
4. What impact will the new rules have on U.S. agri-
culture?
The strict labeling and traceability requirements
introduced by the new regulation are expected to do two
things.
First, they will impose very high transaction costs on
the GM food supply chain that will have to trace GMOs at
all stages of production. Some of these costs will be
transferred to the consumer of GMPs, which will further
reduce the “appeal” of these products in Europe.
Second, if the polls on European consumer attitudes
toward GMPs mean anything at all, labeling of GMPs
cannot increase consumer acceptance of these products - the
market for these products in Europe seems to be quite small
(and if extra costs imposed by the new rules are transferred
to the consumer, they will make it even smaller).
As a conclusion, I would like to point out that I view
the new EU regulation on GMOs as ingenious in achieving
the EU objectives as (1) it makes exports of GMPs to the
EU very costly, (2) it will not increase the market accep-
tance of GMOs in Europe, (3) it deters adoption of biotech-
nology in developing countries, and (4) it is consistent with
the WTO position on the issue that backs strict labeling of
GMPs.
The introduction of strict traceability and labeling
requirements is not a good development for either the U.S.
agriculture or the agricultural biotechnology sector.
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